Sweetening Drug Delivery for Future Therapies: Hydrogels Based on Sugars for Biomedical Applications
Sweetening Drug Delivery for Future Therapies: Hydrogels Based on Sugars for Biomedical Applications
批准号:
1777178
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hydrogels are 3D, cross-linked networks of water-soluble polymers, and formulated in a variety of physical forms (slabs, microparticles, nanoparticles...). Hydrogels show great promise in biomedical applications, drug delivery in particular, but also in clinical practice and experimental medicine for a wide range of applications (tissue engineering, regenerative medicine, diagnostics, cellular immobilization, separation of biomolecules or cells). Within the broad chemical family of "sugars", polysaccharides are excellent biopolymers for hydrogel preparation in biomedical contexts: they are non-toxic, water-soluble with high capability for swelling induced by simple chemical modifications, and they can be biodegraded to nontoxic products that are easily assimilated by the body. Great advances in polymer preparation for hydrogels (enzymatic procedures, nanocomposites, etc.) needs to be followed by an understanding at molecular level of the processes of gelation, the role of water, and the impact on final performance. In this project we will use state-of-the-art NMR spectroscopy (solution, solid, and gel state advanced experiments) to deepen our understanding of the molecular details of novel hydrogel materials based on starch and nanocellulose fibres. We will use cutting-edge glycobiology techniques (enzymatic and click chemistry) for functionalisation of nanocrystalline cellulose, prepare advanced materials (nanocomposite and interpenetrating network hydrogels), and will develop novel NMR spectroscopic protocols to understand the structure and dynamics of the biomaterials.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/chem.202003604
发表时间:
2021-01-18
期刊:
Chemistry (Weinheim an der Bergstrasse, Germany)
影响因子:
--
作者:
[de Andrade P, Muñoz-García JC, Pergolizzi G, Gabrielli V, Nepogodiev SA, Iuga D, Fábián L, Nigmatullin R, Johns MA, Harniman R, Eichhorn SJ, Angulo J, Khimyak YZ, Field RA]
通讯作者:
Field RA
DOI:
10.1007/s10570-018-02225-8
发表时间:
2019-01-01
期刊:
CELLULOSE
影响因子:
5.7
作者:
[Nigmatullin, Rinat, Gabrielli, Valeria, Eichhorn, Stephen J.]
通讯作者:
Eichhorn, Stephen J.
Spin Diffusion Transfer Difference (SDTD) NMR: An Advanced Method for the Characterisation of Water Structuration Within Particle Networks
自旋扩散传递差 (SDTD) NMR:一种表征粒子网络内水结构的先进方法
DOI:
10.26434/chemrxiv.12770813.v1
发表时间:
2020
期刊:
影响因子:
--
作者:
[Gabrielli V]
通讯作者:
Gabrielli V
DOI:
10.1016/j.microc.2020.104754
发表时间:
2020-06-01
期刊:
MICROCHEMICAL JOURNAL
影响因子:
4.8
作者:
[Invernizzi, Claudia, Fiocco, Giacomo, Malagodi, Marco]
通讯作者:
Malagodi, Marco
国内基金
海外基金
登录
查看更多内容
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
-
批准号:61372188
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:陈秀杰
-
依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
-
批准号:61073135
-
项目类别:面上项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:梅虎
-
依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
-
批准号:20776012
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2007
-
负责人:张慧
-
依托单位:
用Drug-Western法分离恶性疟原虫cDNA编码的青蒿素类药物结合蛋白
-
批准号:30070681
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2000
-
负责人:程远国
-
依托单位: